Product NDC: | 55289-132 |
Proprietary Name: | Detrol LA |
Non Proprietary Name: | tolterodine tartrate |
Active Ingredient(s): | 4 mg/1 & nbsp; tolterodine tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-132 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021228 |
Marketing Category: | NDA |
Start Marketing Date: | 20000222 |
Package NDC: | 55289-132-21 |
Package Description: | 21 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55289-132-21) |
NDC Code | 55289-132-21 |
Proprietary Name | Detrol LA |
Package Description | 21 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (55289-132-21) |
Product NDC | 55289-132 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | tolterodine tartrate |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20000222 |
Marketing Category Name | NDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | TOLTERODINE TARTRATE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |